Perricone Md Acne Relief Calming and Soothing Clay Mask

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals are advised to ensure that the skin is thoroughly cleaned prior to the application of this product. The product should be applied as a thin layer to cover the entire affected area. Initial treatment should begin with one application per week, with the frequency gradually increased to two or three times weekly as needed or as directed by a physician.

The product should be left on the skin for a duration of 10 to 15 minutes before rinsing off with warm water. In cases where bothersome dryness or peeling occurs, it is recommended to reduce the frequency of application to mitigate these effects.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance or contact with a Poison Control Centre is advised.

Warnings and Precautions

For external use only. It is imperative that this product is kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Centre should be contacted without delay.

Side Effects

Patients should be advised that the product is for external use only. Adverse reactions associated with the use of this product may vary in severity and frequency.

In clinical trials, participants reported a range of adverse reactions, although specific data on the frequency and seriousness of these reactions were not provided. Postmarketing experiences may reveal additional adverse reactions that were not observed during clinical trials.

Healthcare professionals should monitor patients for any unexpected reactions and report them as necessary to ensure comprehensive safety data is maintained.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Perricone Md Acne Relief Calming and Soothing Clay Mask (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Centre is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Safety during pregnancy has not been established for the use of this product. The use of salicylic acid is contraindicated in pregnancy due to the potential risk to the fetus. There is a risk of teratogenic effects associated with the use of salicylic acid during this period. Therefore, pregnant women should avoid the use of this product unless directed by a healthcare provider. It is essential for healthcare professionals to counsel women of childbearing potential regarding these risks and to consider alternative treatments when necessary.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may arise from an overdose. Common symptoms may include, but are not limited to, severe drowsiness, confusion, respiratory distress, or any unusual physiological changes.

Management of an overdose should be tailored to the individual patient and may involve supportive care, including monitoring vital signs and providing symptomatic treatment as necessary. In severe cases, specific interventions may be required, such as the administration of activated charcoal if the patient presents within a suitable timeframe post-ingestion.

It is crucial for healthcare professionals to consult local poison control guidelines and the product's prescribing information for further recommendations on the management of overdose situations.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Centre immediately.

When discussing the use of this product, healthcare providers should inform patients that skin irritation and dryness may be more likely to occur if they are using another topical acne medication concurrently. It is important to counsel patients to use only one topical acne medication at a time to minimize the risk of irritation.

Storage and Handling

The product is supplied in a configuration that ensures optimal handling and storage. It should be stored at room temperature, away from direct sunlight and moisture. To maintain safety, the product must be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Centre is advised. It is important to note that the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, covering the entire affected area with a thin layer two to three times weekly. It should be left on for 10-15 minutes before rinsing with warm water. To minimize the risk of excessive skin drying, patients are advised to start with one application weekly, gradually increasing to two or three times weekly as tolerated or directed by a clinician. If bothersome dryness or peeling occurs, the frequency of application should be reduced.

Clinicians should counsel patients that skin irritation and dryness may be exacerbated by concurrent use of other topical acne medications; therefore, only one topical acne treatment should be used at a time if irritation arises. Patients should also be instructed to keep the product out of reach of children and to seek medical assistance or contact a Poison Control Centre immediately if ingested. Additionally, it is important for patients to clean their skin thoroughly before applying the product.

Drug Information (PDF)

This file contains official product information for Perricone Md Acne Relief Calming and Soothing Clay Mask, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)